Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
A United States District Court judge on Thursday ruled that the Federal Emergency Management Agency (FEMA) was wrong to cancel a program that has funded infrastructure resiliency efforts in ...
Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...
If only they were robotic! Instead, chatbots have developed a distinctive — and grating — voice. Credit...Illustration by Giacomo Gambineri Supported by By Sam Kriss In the quiet hum of our digital ...
Assistant Teaching Professor of Global Arts, Media and Writing Studies, University of California, Merced Ordinary and universal, the act of writing changes the brain. From dashing off a heated text ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best mid cap stocks to buy according to hedge funds. On November 1, TD Cowen analyst Brendan Smith touted the progress the company has made ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...
NASHVILLE, Tenn. (WSMV) - Tennessee’s new private school voucher program, which provides $7,300 to 20,000 students in its first year, could more than double in size in 2026, a move projected to cost ...
DNA Vibe appointed Maria Del Rio as its chief marketing officer. Magnet Biomedicine appointed Bharat Reddy as chief business officer. Target RWE named Sriram Krishnan, PhD as chief product officer.
A growing number of special education teachers say they use artificial intelligence platforms to draft all or part of students’ individualized education programs, even as many districts lack policies ...
When financial writers discuss money, the focus is usually on acquisition—i.e., how to maximize your portfolio. I’ve contributed my fair share to the pile of advice, which can be distilled into this ...
For many retirees, the challenge isn't just making their money last. It's figuring out how to access the wealth they've already built. With inflation still pushing up the cost of groceries, gas and ...